Minerva Neurosciences (NERV) Misses Q3 EPS by 26c

Minerva Neurosciences (NASDAQ: NERV) reported Q3 EPS of ($1.03), $0.26 worse than the analyst estimate of ($0.77).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Is the S&P 500 in an "earnings bubble"? Goldman weighs in
• DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2